[Ultrastructural analysis of mouse levator auris longus muscle intoxicated in vivo by botulinum neurotoxin type A]
- PMID: 19245166
[Ultrastructural analysis of mouse levator auris longus muscle intoxicated in vivo by botulinum neurotoxin type A]
Abstract
We studied the short and long term ultrastructural changes produced by botulinum neurotoxin type A injected in vivo, at a sublethal dose, in mouse levator auris longus muscle. The neurotoxin had a temporary effect on nerve terminals which consisted in a generalized paralysis, that affected the following features of the neuromuscular sample's morphology: size of the nerve terminals, vesicle population, mitochondrial appearance, Schwann cell's morphology, development and distribution of post-synaptic membrane folds, and nuclear morphology of the different elements of the motor end plate. Besides, the amount of endomysial connective tissue was significantly greater compared to non-intoxicated cases, and these changes were more notorious during the first couple of weeks. 20 to 25 days after the injection, during the recovery phase, we observed nerve terminals with a variable appearance: some completely degenerated, enveloped by Schwann cell processes, and new contacts characterized ultrastructurally for their small size, scarce vesicles, partially enveloped by Schwann cells, early myelinized axons and barely developed synaptic folds. Sixty days after the injection, the axon terminal recovered its normal appearance: synaptic vesicles filled the axon's cytoplasm, and the mitochondria showed normal appearing cristae and electronic densities. We conclude that botulinum neurotoxin type A produces changes related to denervation of the nerve terminals and affects the motor end plate components. Schwann cells play an important role both in the morphofuntional recovery of nerve terminals and in their degradation.
Similar articles
-
Upregulation of calcitonin gene-related peptide at mouse motor nerve terminals poisoned with botulinum type-A toxin.Pflugers Arch. 1996;431(6 Suppl 2):R297-8. doi: 10.1007/BF02346386. Pflugers Arch. 1996. PMID: 8739382
-
Capsaicin protects mouse neuromuscular junctions from the neuroparalytic effects of botulinum neurotoxin a.J Pharmacol Exp Ther. 2009 Nov;331(2):361-71. doi: 10.1124/jpet.109.156901. Epub 2009 Aug 4. J Pharmacol Exp Ther. 2009. PMID: 19654265 Free PMC article.
-
Perturbation to Cholesterol at the Neuromuscular Junction Confers Botulinum Neurotoxin A Sensitivity to Neonatal Mice.Toxicol Sci. 2017 Sep 1;159(1):179-188. doi: 10.1093/toxsci/kfx127. Toxicol Sci. 2017. PMID: 28645175 Free PMC article.
-
Trophic interrelations at the neuromuscular junction as revealed by the use of botulinal neurotoxins.J Physiol (Paris). 1990;84(2):167-73. J Physiol (Paris). 1990. PMID: 2290131 Review.
-
More than at the neuromuscular synapse: actions of botulinum neurotoxin A in the central nervous system.Neuroscientist. 2015 Feb;21(1):44-61. doi: 10.1177/1073858414524633. Epub 2014 Feb 26. Neuroscientist. 2015. PMID: 24576870 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources
Medical